Array Biopharma Inc (NASDAQ:ARRY)

19.37
Delayed Data
As of Jun 22
 -0.18 / -0.92%
Today’s Change
7.15
Today|||52-Week Range
20.21
+51.33%
Year-to-Date

Today’s Trading

Previous close19.55
Today’s open19.75
Day’s range18.86 - 19.88
Volume4,239,240
Average volume (3 months)2,697,313
Market cap$3.3B
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-10.77%
Earnings growth (this year)-2.99%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.41%
P/E ratioNM
Price/Sales9.06
Price/Book230.35

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.69+1.51%
MYOKMyoKardia Inc+0.50+1.04%
CBMCambrex Corp+0.10+0.21%
TBPHTheravance Biopharma...-0.16-0.66%
Data as of 4:03pm ET, 06/22/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$150.9M
Annual profit (last year)-$116.8M
Net profit margin-77.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts